Xospata

Xospita (gilteritinib) is an oral prescription medicine used for the treatment of certain types of acute myeloid leukemia. This overview covers its general use, effects, and safety considerations for patient reference.

Gilteritinib is primarily used to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. It belongs to a class of medications that help slow the progression of cancer by targeting certain proteins in leukemia cells. Patients often ask, 'what is gilteritinib used for' in the context of AML treatment.

Gilteritinib works by interfering with the growth of cancer cells, which may help reduce symptoms associated with AML. Many patients notice changes in their energy levels and overall well-being as their condition is managed. It is important to monitor how the body responds during treatment.

This medication should be taken exactly as prescribed by a healthcare provider. Patients should inform their doctor about all current medications and health conditions before starting gilteritinib. Regular blood tests are often required to track response and side effects during treatment.

Gilteritinib may interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Combining it with strong CYP3A4 inhibitors or inducers can affect how the drug works. Alcohol and grapefruit products may also influence its effectiveness or side effects.